0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 61-80 of 767 Articles
JAMA Oncology | 
Original Investigation |  Open Access
Richard J. Bleicher, MD; Karen Ruth, MS; Elin R. Sigurdson, MD, PhD; et al.
JAMA Oncol. 2016;2(3):330-339. doi:10.1001/jamaoncol.2015.4508.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Adrienne G. Waks, MD; Tari A. King, MD; Eric P. Winer, MD
JAMA Oncol. 2016;2(3):302-304. doi:10.1001/jamaoncol.2015.4506.

JAMA Surgery | 
Invited Commentary |  ONLINE FIRST
Uttara Nag, MD; E. Shelley Hwang, MD, MPH
JAMA Surg. Published online February 17, 2016. doi:10.1001/jamasurg.2015.5555

JAMA Surgery | 
Original Investigation |  ONLINE FIRST
Abby J. Isaacs, MS; Mary L. Gemignani, MD, MPH; Andrea Pusic, MD, MHS, FRCSC; et al.
JAMA Surg. Published online February 17, 2016. doi:10.1001/jamasurg.2015.5535
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Teresa K. Woodruff, PhD; Kristin Smith, BS; William Gradishar, MD
JAMA Oncol. 2016;2(2):171-172. doi:10.1001/jamaoncol.2015.5609.

JAMA Oncology | 
Brief Report | 
Jashodeep Datta, MD; Megan Fracol, MD; Matthew T. McMillan, BA; et al.
JAMA Oncol. 2016;2(2):242-246. doi:10.1001/jamaoncol.2015.5482.
Includes: Supplemental Content

JAMA Oncology | 
Research Letter | 
Jordan D. Lane, MD; Mark W. Friedberg, MD, MPP; Charles L. Bennett, MD, PhD, MPP
JAMA Oncol. 2016;2(2):274-276. doi:10.1001/jamaoncol.2015.3928.

JAMA Oncology | 
Editorial | 
Jee Ye Kim, MD; Seung-il Kim, MD, PhD; Soonmyung Paik, MD
JAMA Oncol. 2016;2(2):180-182. doi:10.1001/jamaoncol.2015.4343.

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Michail Ignatiadis, MD, PhD; Hatem A. Azim Jr, MD, PhD; Christine Desmedt, PhD; et al.
JAMA Oncol. 2016;2(2):217-224. doi:10.1001/jamaoncol.2015.4377.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Amy S. Clark, MD, MSCE; Thomas B. Karasic, MD; Angela DeMichele, MD, MSCE; et al.
JAMA Oncol. 2016;2(2):253-260. doi:10.1001/jamaoncol.2015.4701.
Includes: CME, Supplemental Content

JAMA Oncology | 
Invited Commentary | 
David Warr, MD, FRCPC; Carlo DeAngelis, PharmD; Edward Chow, MBBS
JAMA Oncol. 2016;2(2):232-233. doi:10.1001/jamaoncol.2015.3757.

JAMA Oncology | 
Original Investigation | 
Mark Clemons, MD; Nathaniel Bouganim, MD; Stephanie Smith, BA; et al.
JAMA Oncol. 2016;2(2):225-231. doi:10.1001/jamaoncol.2015.3730.
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network | 
Michael LeBlanc, PhD; Catherine Tangen, DrPH
JAMA Oncol. 2016;2(2):263-264. doi:10.1001/jamaoncol.2015.4711.

JAMA Oncology | 
From The JAMA Network | 
Heidi D. Nelson, MD, MPH
JAMA Oncol. 2016;2(2):261-262. doi:10.1001/jamaoncol.2015.4096.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(2):123. doi:10.1001/jama.2015.17834.

JAMA | 
Original Investigation |  FREE
Lorelei A. Mucci, ScD, MPH; Jacob B. Hjelmborg, PhD; Jennifer R. Harris, PhD; et al.
JAMA. 2016;315(1):68-76. doi:10.1001/jama.2015.17703.
Includes: CME, Supplemental Content

JAMA Oncology | 
Editorial | 
Sylvia Adams, MD, MS
JAMA Oncol. 2016;2(1):25-27. doi:10.1001/jamaoncol.2015.3236.

JAMA Oncology | 
Original Investigation | 
Edith A. Perez, MD; Karla V. Ballman, PhD; Kathy S. Tenner, BS; et al.
JAMA Oncol. 2016;2(1):56-64. doi:10.1001/jamaoncol.2015.3239.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Oncology
Review  | 
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes A Systematic Review
Sasha E. Stanton, MD, PhD; Sylvia Adams, MD; Mary L. Disis, MD
JAMA Oncology
Original Investigation  | 
Trastuzumab-Related Cardiotoxic Effects in Taiwanese Women A Nationwide Cohort Study
Hsu-Chih Chien, MS; Yea-Huei Kao Yang, BSPharm; Jane P. F. Bai, AM, PhD